Register and share your invite link to earn from video plays and referrals.

Search results for TCC2026
TCC2026 community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including TCC2026
Live from #TCT2026#, hear Dr. @RhianEDavies1 and Dr. Nick West discuss her recently presented CAD DUO one-year results and her early experience with the 2x-faster pulsing #ShockwaveC2AeroFly#. Read the CAD DUO 30-day results in @JACCJournals: Read the CAD DUO one-year results in @AmJCardio: US Rx only. Safety info: Product availability may vary by country.
Show more
That’s a wrap on #TCT2026#. ❤️ This week was all about learning and connecting with the physicians and customers who continue to advance the treatment of coronary calcium with us. Together, we celebrated the launch of #ShockwaveC2AeroFly#, went hands-on with our latest innovation, explored the unique science behind #ShockwaveIVL#, and heard invaluable perspectives from the interventional cardiology community. Thank you to the physicians, customers, partners and Johnson & Johnson colleagues who brought their expertise, curiosity and energy to every conversation, demonstration and educational experience. You made this TCT one to remember. US Rx only. Safety info: Product availability may vary by country.
Show more
In advance of the live presentation at #TCT2026#, @AmJCardio released the one-year outcomes of the DISRUPT CAD Duo trial, studying the novel 2 Hz coronary #ShockwaveIVL# catheter for calcified coronary artery disease. Congratulations to Dr. @matthewjpricemd and the CAD Duo investigators on the publication. Check out the publication and attend the one-year results of the CAD Duo IDE study presentation by Dr. @RhianEDavies1 on Monday at 10:30 AM PT at TCT. Read the article: US Rx only. Safety info: Product availability may vary by country.
Show more
Take #ShockwaveC2AeroFly# for a test flight at #TCT2026#. ⚡✈️ Join the PCI Skills Pavilion and hear from Drs. James Spratt (@jcspratt), Leah Raj, Thuy Ryan (@ThuyPhamDO), Carlos Collet (@ColletCarlos), Salman Arain (@DrSalmanArain), and Dhananjay Chatterjee (@dchatterjee824) as they discuss how angiography, CCTA, and intravascular imaging can help identify and assess calcium, followed by hands-on experience with #ShockwaveC2AeroFly#. 📅 Monday, November 2 | 2:00-3:30 PM and 4:00-5:30 PM Build your TCT flight plan and join our circulatory restoration solutions Training Pavilion:  @TCTConference #ShockwaveIVL# #JNJMedTech# Presenting physicians are paid consultants of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.
Show more
Don't miss these key data presentations at #TCT2026#. 📍 From featured research to real-world evidence, join these four sessions to discover the latest innovations across our Shockwave IVL portfolio: ⚡ NODULE-SHOCK, presented by Dr. Annapoorna Kini (@DoctorKini) ⚡ AeroCAD, presented by Dr. Ziad Ali (@ziadalinyc) ⚡ CAD DUO 1-Year Results, presented by Dr. Rhian E. Davies (@RhianEDavies1) ⚡ FORWARD CAD 30-Day Results, presented by Dr. Robert W. Yeh (@rwyeh) Stay updated on all things TCT:  @TCTConference #JNJMedTech# US Rx only. Safety Info: Product availability may vary by country.
Show more
We're red, full speed ahead at #TCT2026# ❤️ @JNJMedTech's circulatory restoration solutions are live at TCT with a new look, now making even bigger waves with the proven #ShockwaveIVL# technology physicians know and trust. Stop by the booth to experience our new look, sip a coffee and get hands-on with the new 2x-faster pulsing #ShockwaveC2AeroFly#. US Rx only. Safety info: Product availability may vary by country.
Show more
#ShockwaveC2AeroFly# has taken flight across America. Next stop: #TCT2026# ✈️ Congratulations to the physicians and cath lab teams behind the first commercial cases, experiencing the benefits of 2x-faster pulsing firsthand. Join us at TCT as #ShockwaveCoronaryIVL# continues to lead the conversation around the treatment of complex coronary calcification. Attend the Training Pavilion sessions or visit our booth to experience our next-generation #CoronaryIVL# catheter firsthand. ⚡ Explore all we're bringing to TCT:  Drs. Ziad Ali (@ziadalinyc), Rich Shlofmitz, Evan Shlofmitz (@ESHLOF), Paul Sapia (@PaulSap9), Allen Jeremias (@DrAllenJ), Annapoorna Kini (@DoctorKini), Samin Sharma, Amit Hooda (@AmithoodaMD), Prashant Kaul (@KaulP), Hector Tamez (@hectortamezmd), Robert Stoler, Subhash Banerjee, Chadi Dib, Karim Al-Azizi (@kalazizimd), Emmanouil Brilakis (@esbrilakis), and Yousif Ahmad US Rx only. Safety Info: Product availability may vary by country.
Show more
Bye, bye blue — when you see us at #TCT2026#, we'll be red with excitement! Shockwave Medical is now @JNJMedTech, so make sure to stop by our booth to see our new shade of bold and learn how our impact has been amplified by the global leader in healthcare⚡​ Discover what we have red-y for you at this year's conference:
Show more
A Featured Clinical Research session you won't want to miss at #TCT2026#: FORWARD CAD 30-day results. ⚡ Join Dr. Robert W. Yeh (@rwyeh) as he presents new 30-day results from the FORWARD CAD IDE study evaluating Shockwave Javelin Coronary IVL in challenging coronary lesions and discusses the future of this innovative technology. 📅 Sunday, November 1 ⏰ 12:58 PM PT 📍 Coronary Live Case Theater, Ground Level, Halls A-B, San Diego Convention Center Meet us as @JNJMedTech circulatory restoration solutions for the first time and plan your TCT schedule with our featured studies, sessions, and education:  @TCTConference #ShockwaveIVL# #JNJMedTech# Caution: Investigational device. Limited by Federal (U.S) law to investigational use only. Outside the U.S., the device is subject to local regulatory requirements and is not commercially available.
Show more
The largest real-world data set yet for Shockwave Coronary IVL, presented at #TCT2026#.⚡ The CathPCI Registry data set analyzed more than 250,000 #ShockwaveCoronaryIVL# outcomes, offering a powerful look at its use in everyday practice, including highly complex #ComplexPCI# cases with 79.3% high complexity lesions and 55.8% multivessel disease. The findings support consistent, predictable coronary performance in real-world practice. Thank you to Dr. @PrakritiGaba for presenting these important findings and bringing insights from this extensive data set to the field. US Rx only. Safety info: Product availability may vary by country.
Show more